Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

360
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
360

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interaction between smoking and <i>HLA-A*02:01</i> in multiple sclerosis progression.

Multiple sclerosis (Houndmills, Basingstoke, England)Ā·2026
Same author

Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study.

Multiple sclerosis (Houndmills, Basingstoke, England)Ā·2026
Same author

Temporal trends in the incidence and prevalence of multiple sclerosis in Sweden 2001-2021.

NeuroepidemiologyĀ·2026
Same author

Trajectories of processing speed in multiple sclerosis across disease-modifying therapies.

Journal of neurologyĀ·2026
Same author

Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.

Multiple sclerosis (Houndmills, Basingstoke, England)Ā·2026
Same author

A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.

European journal of epidemiologyĀ·2026

Related Experiment Video

Updated: Oct 7, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.2K

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse.

Kyla A McKay1,2, Sahl K Bedri1,2, Ali Manouchehrinia1,2

  • 1Department of Clinical Neuroscience, Neuro Division, Karolinska Institutet, Stockholm, Sweden.

Annals of Neurology
|January 5, 2022
PubMed
Summary

Multiple sclerosis relapses significantly impact cognitive processing speed for up to 1.5 years. This decline begins before relapse and highlights the need to reduce relapse frequency to preserve cognitive function in relapsing-remitting MS patients.

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.5K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

Related Experiment Videos

Last Updated: Oct 7, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.2K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.5K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

Area of Science:

  • Neurology
  • Neuroscience
  • Cognitive Science

Background:

  • Relapsing-remitting multiple sclerosis (MS) is characterized by unpredictable neurological attacks.
  • Cognitive impairment, particularly in information processing speed, is a common but often underestimated symptom of MS.
  • The precise temporal relationship between MS relapses and cognitive function decline requires further elucidation.

Purpose of the Study:

  • To investigate the longitudinal association between multiple sclerosis (MS) relapses and information processing efficiency in individuals with relapsing-remitting MS.
  • To determine the duration and severity of cognitive changes relative to MS relapse events.

Main Methods:

  • A Swedish nationwide cohort study included individuals diagnosed with relapsing-remitting MS between 2001 and 2019.
  • Symbol Digit Modalities Test (SDMT) scores and relapse data were collected from the Swedish MS Registry.
  • Linear mixed models were used to compare SDMT scores during relapse periods (pre- and post-relapse) with scores during remission, adjusting for relevant covariates.

Main Results:

  • A significant decline in information processing efficiency was observed starting 30 days before a relapse and lasting up to 550 days post-relapse.
  • The most substantial decrease in SDMT scores occurred within the first 30 days following a relapse.
  • Cognitive function remained significantly impaired for up to 1.5 years, with clinically significant effects lasting 3 months post-relapse.

Conclusions:

  • MS relapses have a prolonged and significant negative impact on cognitive processing efficiency, extending beyond the acute relapse phase.
  • Cognitive changes can precede MS relapses, suggesting a complex interplay between disease activity and cognitive function.
  • Reducing the frequency of MS relapses may be a crucial strategy for preserving long-term cognitive function in patients with relapsing-remitting MS.